Sansure Biotech (SHSE:688289) Change In Payables And Accrued Expense : ¥0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Sansure Biotech Change In Payables And Accrued Expense?

Sansure Biotech's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2025 was ¥0 Mil. It means Sansure Biotech's Accounts Payable & Accrued Expense stayed the same from Dec. 2024 to Mar. 2025 .

Sansure Biotech's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2024 was ¥0 Mil. It means Sansure Biotech's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Dec. 2024 .

Sansure Biotech Change In Payables And Accrued Expense Historical Data

The historical data trend for Sansure Biotech's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sansure Biotech Change In Payables And Accrued Expense Chart

Sansure Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Sansure Biotech Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Sansure Biotech Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Sansure Biotech Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Sansure Biotech's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Sansure Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sansure Biotech Inc (SHSE:688289) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 680, Lusong Road, Changsha High-tech Industrial Development Zone, Hunan Province, Changsha, CHN, 410205

Website

http://www.sansure.com.cn

Sansure Biotech Inc is engaged in production and sales of diagnostic reagents and instruments. The company produces Class I medical devices, Class II medical devices, Class III medical devices, general instruments and meters, medical raw materials, medical laboratory equipment and appliances, and medical accessories.

Executives

Tan De Yong	Core technical personnel
Wang Hai Xiao	senior management
Jie Ya Ping	Core technical personnel
Zhang Ke Ya	Core technical personnel
Yang Li	Core technical personnel
Liu Rang Jiao	Core technical personnel
Deng Zhong Ping	Senior management, core technical personnel
Zhou Jun	senior management
Zhu Jian	senior management
Wu Kang	Core technical personnel
Xiong Xiao Yan	senior management
Ji Bo Zhi	Core technical personnel
Mou Wei Min	Core technical personnel
Ren Xiao Mei	Core technical personnel
Liu Kai	senior management

Sansure Biotech Headlines

No Headlines